Login to Your Account



Lilly Plans Hypnion Takeover, Getting Phase II Insomnia Drug

By Randall Osborne


Tuesday, March 6, 2007
Less than two months after Phase II success with its insomnia drug, privately held Hypnion Inc. is being taken over by Eli Lilly and Co. for undisclosed terms. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription